Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

400

HTML

4310

Figures (1-3)

362

Tables (1-6)

366

Sum=5438

Jan 7, 2008 (publication date) through May 3, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 7, 2008; 14(1): 58-63
Published online Jan 7, 2008. doi: 10.3748/wjg.14.58

Table 4 The 3-year survival rates in each score of mJIS after treatments in HCC patients

Citation: Nanashima A, Masuda J, Miuma S, Sumida Y, Nonaka T, Tanaka K, Hidaka S, Sawai T, Nagayasu T. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008; 14(1): 58-63
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/58.htm
DOI: https://dx.doi.org/10.3748/wjg.14.58